Novartis Investigative Site

Greenbrae, California 94904-2007

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Renal Cell, Metastases, Brain, Non-Hodgkin's Lymphoma

Studies at this site

• Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma — Completed
• Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer — Completed
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early